FDA Adverse Event
Malfunction
Summary report: N
SESTAMIBI-R-
MDR report key: 2240771
·
Received September 2, 2011
Report
- Report Number
- MW5022124
- Event Type
- Malfunction
- Date Received
- September 2, 2011
- Date of Event
- August 24, 2011
- Report Date
- September 2, 2011
- Manufacturer
- PHARMALOGIC
- Product Code
- KTA
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- NY, US
- Reporter Occupation
- PHARMACIST
Narratives
Description of Event or Problem · 1
(B)(6) REPORTED ON (B)(6) 2011 THAT THEY WERE AWARE OF A ALTERED BIODISTRIBUTION ISSUE WITH SESTAMIBI-R- DUE TO A GENERATOR MALFUNCTION. LOT AFFECTED WAS 1134. PRODUCT PASSED THE COMPANY'S QI AND ASSAYED FOR THE CORRECT AMOUNTS OF SESTAMIBI-R-. HOWEVER, AFFECTED PT'S HEART WAS UNABLE TO BE VISUALIZED ON NUCLEAR SCAN DURING CARDIAC STRESS TESTING DUE TO THE INCREASED UPTAKE BY OF THE RADIOISOTOPE BY THE STOMACH AND BOWEL. PATIENT DID NOT SUFFER ANY HARM, BUT IS INCONVENIENCED BY HAVING THE TEST REPEATED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SESTAMIBI-R- | SESTAMIBI-R- | KTA | PHARMALOGIC | 1134 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Other |